Investment Announcement
23 Mar 2026
News & Insights
Investment Announcement
13 Mar 2026
Claret Capital Partners Invests €28M in Cinclus Pharma
View Claret Capital Partners Invests €28M in Cinclus Pharma
Investment Announcement
10 Mar 2026
Claret Capital Partners Announces Investment in U.S.-based ACT LAB
View Claret Capital Partners Announces Investment in U.S.-based ACT LAB
Portfolio News
11 Feb 2026
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
View Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
Claret Insight
28 Jan 2026
The GLP-1 Pill Race: Pharma’s New Frontier
View The GLP-1 Pill Race: Pharma’s New Frontier
Portfolio News
14 Jan 2026
Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.
View Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.
Investment Announcement
14 Jan 2026
Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
View Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A
Investment Announcement
8 Jan 2026